Career history of Motoji Horiguchi
Former positions of Motoji Horiguchi
| Companies | Position | Start | End |
|---|---|---|---|
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Human Resources Officer | 2004-12-31 | 2004-12-31 |
| Public Communications Contact | 2004-12-31 | 2004-12-31 | |
Takeda BIO Development Center Ltd.
 Takeda BIO Development Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda BIO Development Center Ltd. manufactures and markets human therapeutics. | Corporate Officer/Principal | - | - |
| PANASONIC HOLDINGS CORPORATION | Corporate Officer/Principal | 1967-12-31 | - |
Statistics
International
| Japan | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Human Resources Officer | 1 |
| Public Communications Contact | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PANASONIC HOLDINGS CORPORATION | Consumer Durables |
| Private companies | 2 |
|---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
Takeda BIO Development Center Ltd.
Takeda BIO Development Center Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda BIO Development Center Ltd. manufactures and markets human therapeutics. | Health Technology |
- Stock Market
- Insiders
- Motoji Horiguchi
- Experience
